Jocelyn V. Wainwright

Jocelyn V. Wainwright

Auto-generated profile, based on publicly available information

Jocelyn V. Wainwright

Department of Family Medicine & Community Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2024 in JNCI Monographs
Verified
Journal Article
Open access
PDF file
KRKatharine A Rendle
Katharine A Rendle
ATAndy SL Tan
Andy SL Tan
BSBonnie Spring
Bonnie Spring
EBErin M Bange
Erin M Bange
ALAllison Lipitz-Snyderman
Allison Lipitz-Snyderman
JBJustin E Bekelman
Justin E Bekelman
The COVID-19 pandemic placed a spotlight on the potential to dramatically increase the use of telehealth across the cancer care continuum, but whether and how telehealth can be implemented in practice in ways that reduce, rather than exacerbate, inequities are largely unknown. To help fill this critical gap in research and practice, we developed the Framework for Integrating Telehealth Equitably (FITE), a process and evaluation model designed to help guide equitable integration of telehealth into practice. In this manuscript, we present FITE and showcase how investigators across the National Cancer Institute’s Telehealth Research Centers of Excellence are applying the framework in different ways to advance digital and health equity. By highlighting multilevel determinants of digital equity that span further than access alone, FITE highlights the complex and differential ways structural determinants restrict or enable digital equity at the individual and community level. As such, achieving digital equity will require strategies designed to not only support individual behavior but also change the broader context to ensure all patients and communities have the choice, opportunity, and resources to use telehealth across the cancer care continuum.

1 January 2025 in MDM Policy & Practice
Verified
Journal Article
Open access
JLJennifer A. Elston Lafata
Jennifer A. Elston Lafata
KRKatharine A. Rendle
Katharine A. Rendle
JWJocelyn V. Wainwright
Jocelyn V. Wainwright
MCMary E. Cooley
Mary E. Cooley
AVAnil Vachani
Anil Vachani
MSMarilyn M. Schapira
Marilyn M. Schapira
Background. Implementing a lung cancer screening (LCS) program with low-dose computed tomography (LDCT) is complex, requiring health care organizations to consider several steps along the screening continuum from eligibility assessment to recommended follow-up testing adherence. The evidence to support LDCT screening implementation remains unclear. Purpose. To summarize interventions facilitating LCS initiation, adoption, or improvement within health care organizations. Data Sources. Librarian-assisted literature reviews identified published studies between January 1, 2011, and December 31, 2023, using CINAHL, Cochrane Library, Embase, Ovid Medline, PsycINFO, and Scopus. Study Selection. Published interventions focusing on any step in the LCS process before lung cancer diagnosis, including risk/eligibility assessment, shared decision making (SDM), and annual screening or diagnostic testing. Data Abstraction. We used a title/abstract review process, full-text review, and risk-of-bias assessments. We characterized studies by design, unit of observation, participant sociodemographic characteristics, primary outcome, and step in the LCS process. DistillerSR and Covidence were used for data management. Data Synthesis. We identified 64 study-eligible published articles, including 19 randomized and 45 nonrandomized studies. SDM interventions were most frequently studied ( n = 20) followed by initial LCS uptake ( n = 12). Most studies ( n = 33) evaluated educational interventions, typically in one-on-one settings. Studies assessed at either low or moderate/some risk of bias reported statistically significant findings in the domains of improved knowledge ( n = 7) and other aspects of decision making ( n = 8), such as perceived risk or decisional conflict. Findings regarding LCS uptake were more variable. Limitations. The review includes only English-language studies published prior to 2024. The risk of bias was high among 5 of the randomized clinical trials and serious among 27 of the quasi-experimental design studies. Conclusions. LCS intervention strategies have focused on SDM and initial LCS uptake, leaving gaps in knowledge about how to support risk and eligibility assessment, adherence to annual screening, or diagnostic testing. Expanding interventions beyond those that are education focused and with single-level targets would expand the LDCT screening implementation evidence base. Highlights: Most lung cancer screening (LCS) interventions evaluated to date have been educational in nature and focused primarily on shared decision making or the initial uptake of screening, with some interventions demonstrating statistically significant improvements in patient knowledge and initial LCS order/uptake. A critical gap in knowledge remains regarding how to effectively support LCS eligibility assessment as well as adherence to annual screening and appropriate diagnostic testing. Findings underscore the need for the field to expand beyond education-focused interventions and incorporate multilevel targets when designing interventions to support high-quality LCS in practice.

26 June 2024 in JNCI Monographs
Verified
Journal Article
Closed access
JWJocelyn V Wainwright
Jocelyn V Wainwright
CACharu Aggarwal
Charu Aggarwal
SBSarah Beucker
Sarah Beucker
DDDavid W Dougherty
David W Dougherty
PGPeter E Gabriel
Peter E Gabriel
JTJoseph Teel
Joseph Teel
Drawing from insights from communication science and behavioral economics, the University of Pennsylvania Telehealth Research Center of Excellence (Penn TRACE) is designing and testing telehealth strategies with the potential to transform access to care, care quality, outcomes, health equity, and health-care efficiency across the cancer care continuum, with an emphasis on understanding mechanisms of action. Penn TRACE uses lung cancer care as an exemplar model for telehealth across the care continuum, from screening to treatment to survivorship. We bring together a diverse and interdisciplinary team of international experts and incorporate rapid-cycle approaches and mixed methods evaluation in all center projects. Our initiatives include a pragmatic sequential multiple assignment randomized trial to compare the effectiveness of telehealth strategies to increase shared decision-making for lung cancer screening and 2 pilot projects to test the effectiveness of telehealth to improve cancer care, identify multilevel mechanisms of action, and lay the foundation for future pragmatic trials. Penn TRACE aims to produce new fundamental knowledge and advance telehealth science in cancer care at Penn and nationally.